317 related articles for article (PubMed ID: 19261371)
1. Combined down-regulation by aromatase inhibitor and GnRH-agonist in IVF patients with endometriomas-A pilot study.
Lossl K; Loft A; Freiesleben NL; Bangsbøll S; Andersen CY; Pedersen AT; Hartwell D; Andersen AN
Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):48-53. PubMed ID: 19261371
[TBL] [Abstract][Full Text] [Related]
2. The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study.
Garcia-Velasco JA; Moreno L; Pacheco A; Guillén A; Duque L; Requena A; Pellicer A
Fertil Steril; 2005 Jul; 84(1):82-7. PubMed ID: 16009161
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of refractory endometriosis-related chronic pelvic pain with aromatase inhibitors in premenopausal patients.
Verma A; Konje JC
Eur J Obstet Gynecol Reprod Biol; 2009 Apr; 143(2):112-5. PubMed ID: 19233536
[TBL] [Abstract][Full Text] [Related]
4. Concomitant treatment of severe uterine adenomyosis in a premenopausal woman with an aromatase inhibitor and a gonadotropin-releasing hormone agonist.
Kimura F; Takahashi K; Takebayashi K; Fujiwara M; Kita N; Noda Y; Harada N
Fertil Steril; 2007 Jun; 87(6):1468.e9-12. PubMed ID: 17222833
[TBL] [Abstract][Full Text] [Related]
5. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report.
Goswami SK; Das T; Chattopadhyay R; Sawhney V; Kumar J; Chaudhury K; Chakravarty BN; Kabir SN
Hum Reprod; 2004 Sep; 19(9):2031-5. PubMed ID: 15217999
[TBL] [Abstract][Full Text] [Related]
6. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status.
Parsanezhad ME; Azmoon M; Alborzi S; Rajaeefard A; Zarei A; Kazerooni T; Frank V; Schmidt EH
Fertil Steril; 2010 Jan; 93(1):192-8. PubMed ID: 19135657
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the effect of short-term aromatase inhibitor (letrozole) and GnRH agonist (triptorelin) versus case control on pregnancy rate and symptom and sign recurrence after laparoscopic treatment of endometriosis.
Alborzi S; Hamedi B; Omidvar A; Dehbashi S; Alborzi S; Alborzi M
Arch Gynecol Obstet; 2011 Jul; 284(1):105-10. PubMed ID: 20661580
[TBL] [Abstract][Full Text] [Related]
8. Aromatase inhibitors prevent the estrogen rise associated with the flare effect of gonadotropins in patients treated with GnRH agonists.
Bedaiwy MA; Mousa NA; Casper RF
Fertil Steril; 2009 Apr; 91(4 Suppl):1574-7. PubMed ID: 18973892
[TBL] [Abstract][Full Text] [Related]
9. Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?
Surrey ES; Lietz AK; Gustofson RL; Minjarez DA; Schoolcraft WB
Fertil Steril; 2010 Feb; 93(2):646-51. PubMed ID: 19171333
[TBL] [Abstract][Full Text] [Related]
10. Ovarian cyst formation following GnRH agonist administration in IVF cycles: incidence and impact.
Qublan HS; Amarin Z; Tahat YA; Smadi AZ; Kilani M
Hum Reprod; 2006 Mar; 21(3):640-4. PubMed ID: 16253965
[TBL] [Abstract][Full Text] [Related]
11. Aromatase inhibitors or gonadotropin-releasing hormone agonists for the management of uterine adenomyosis: a randomized controlled trial.
Badawy AM; Elnashar AM; Mosbah AA
Acta Obstet Gynecol Scand; 2012 Apr; 91(4):489-95. PubMed ID: 22229256
[TBL] [Abstract][Full Text] [Related]
12. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study.
Azim AA; Costantini-Ferrando M; Oktay K
J Clin Oncol; 2008 Jun; 26(16):2630-5. PubMed ID: 18509175
[TBL] [Abstract][Full Text] [Related]
13. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
[TBL] [Abstract][Full Text] [Related]
14. Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study.
Hefler LA; Grimm C; van Trotsenburg M; Nagele F
Fertil Steril; 2005 Oct; 84(4):1033-6. PubMed ID: 16213868
[TBL] [Abstract][Full Text] [Related]
15. Ovarian stimulation for in vitro fertilization in patients with endometriosis.
Zikopoulos K; Kolibianakis EM; Devroey P
Acta Obstet Gynecol Scand; 2004 Jul; 83(7):651-5. PubMed ID: 15225190
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of IVF/ICSI in patients with severe endometriosis after long-term pituitary down-regulation.
van der Houwen LE; Mijatovic V; Leemhuis E; Schats R; Heymans MW; Lambalk CB; Hompes PG
Reprod Biomed Online; 2014 Jan; 28(1):39-46. PubMed ID: 24262434
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitor.
Shippen ER; West WJ
Fertil Steril; 2004 May; 81(5):1395-8. PubMed ID: 15136110
[TBL] [Abstract][Full Text] [Related]
18. A randomized comparison of ovulation induction and hormone profile between the aromatase inhibitor anastrozole and clomiphene citrate in women with infertility.
Wu HH; Wang NM; Cheng ML; Hsieh JN
Gynecol Endocrinol; 2007 Feb; 23(2):76-81. PubMed ID: 17454156
[TBL] [Abstract][Full Text] [Related]
19. A comparison of two months pretreatment with GnRH agonists with or without an aromatase inhibitor in women with ultrasound-diagnosed ovarian endometriomas undergoing IVF.
Cantor A; Tannus S; Son WY; Tan SL; Dahan MH
Reprod Biomed Online; 2019 Apr; 38(4):520-527. PubMed ID: 30935663
[TBL] [Abstract][Full Text] [Related]
20. IVF-ICSI outcome in women operated on for bilateral endometriomas.
Somigliana E; Arnoldi M; Benaglia L; Iemmello R; Nicolosi AE; Ragni G
Hum Reprod; 2008 Jul; 23(7):1526-30. PubMed ID: 18441346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
